SCHEMBL4597758

SCHEMBL4597758

CCCCCC(CCCCC)CC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 10/20 0.63
FFAR1 O14842 3/20 0.50
FFAR4 Q5NUL3 2/20 0.50
LMNA P02545 1/20 0.50
PPARD Q03181 6/20 0.48
MAPT P10636 1/20 0.48
LCK P06239 1/20 0.48
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
AKR1B1 P15121 1/20 0.48
PPARG P37231 5/20 0.46
PPARA Q07869 5/20 0.46
HDAC11 Q96DB2 4/20 0.46
TSHR P16473 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9500437 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL9498754 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL5074106 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL9498760 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL10438736 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL23879500 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL2307490 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL22404400 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL22404039 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD
SCHEMBL5076025 0.98 GPR84 (0.67) GPR84FFAR1FFAR4LMNAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023188830-A1 LIPID NANOPARTICLES 国立大学法人北海道大学 2023-10-05 WO claimed
EP-3178807-B1 CATIONIC LIPID TAKEDA PHARMACEUTICALS CO (JP) 2020-04-29 EP claimed
US-20250205362-A1 LIPID NANOPARTICLES NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2025-06-26 US disclosed
US-20250197343-A1 CATIONIC LIPID TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-06-19 US disclosed
EP-4562154-A2 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE SIGNAL REGULATORY PROTEIN ALPHA (SIRPalpha) GENE Massachusetts Institute of Technology (US) 2025-06-04 EP disclosed
CN-119698302-A Lipid nanoparticles 国立大学法人北海道大学 2025-03-25 CN disclosed
EP-4501359-A1 LIPID NANOPARTICLES National University Corporation Hokkaido University (JP) 2025-02-05 EP disclosed
EP-4431489-A1 CATIONIC LIPID Takeda Pharmaceutical Company Limited (JP) 2024-09-18 EP disclosed
CN-118634318-A Nucleic acid-containing lipid nanoparticles and uses thereof 武田药品工业株式会社 2024-09-13 CN disclosed
CN-118593692-A Nucleic acid-containing lipid nanoparticles and uses thereof 武田药品工业株式会社 2024-09-06 CN disclosed
CN-118512596-A Nucleic acid-containing lipid nanoparticles and uses thereof 武田药品工业株式会社 2024-08-20 CN disclosed
US-5723457-A COMPOUMDS FOR CARDIOVASCULAR DISORDERS AND INHIBITORS OF ANGIOTENSIN CONVERTING ENZYMES E. R. SQUIBB & SONS, INC. (US) 1998-03-03 US disclosed
EP-0651632-B1 HAIR COSMETIC COMPOSITION KAO CORP (JP) 1997-10-15 EP disclosed
US-5587155-A COMPRISING A FATTY ACID, POLYHYDRIC ALCOHOL, AROMATIC ALCOHOL AND AT LEAST ONE QUATERNARY AMMONIUM COMPOUND; HAIR CONDITIONERS KAO CORPORATION (JP) 1996-12-24 US disclosed
EP-0651632-A1 HAIR COSMETIC COMPOSITION. KAO CORP (JP) 1995-05-10 EP disclosed
US-5401604-A Reaction product of polyepoxide, aromatic acid with phenolic hydroxy group, aromatic acid, quinone diazide with sulfonyl group, photoresists NIPPON PAINT CO., LTD. (JP) 1995-03-28 US disclosed
EP-0608894-A1 Positive-type photosensitive resin compositions Nippon Paint Co., Ltd. (JP) 1994-08-03 EP disclosed
WO-1994002111-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 1994-02-03 WO disclosed
US-4325962-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-04-20 US disclosed
US-4146721-A ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205362-A1 LIPID NANOPARTICLES ECH1, C1R, SGMS1 GPR84 1040/4885FFAR1 130/4885FFAR4 603/4885
US-20250197343-A1 CATIONIC LIPID NR1H3, NR1H2, NR1H4 GPR84 494/4885FFAR1 25/4885FFAR4 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.